Hemostatic Disorders  >>  fludarabine IV  >>  Phase 3
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
fludarabine IV / Generic mfg.
NCT00566332: Trial Comparing Chlorambucil to Fludarabine in Patients With Advanced Waldenström Macroglobulinemia

Completed
3
414
Europe
Chlorambucil, Fludarabine
French Study Group on Chronic Lymphoid Leukemia, Lymphoma Study Association, French Innovative Leukemia Organisation, Département de Biostatistiques et Informatique Médicale DBIM
Waldenström Macroglobulinemia, Lymphoplasmacytic Lymphoma, Splenic Marginal Zone Lymphoma
09/09
12/14
NCT00608374: Chlorambucil or Fludarabine as First-Line Therapy in Treating Patients With Previously Untreated Waldenström Macroglobulinemia, Splenic Lymphoma, or Lymphoplasmacytic Lymphoma

Completed
3
400
Europe, RoW
chlorambucil, fludarabine phosphate, quality-of-life assessment
Taunton and Somerset Hospital
Lymphoma
12/09
01/13
NCT00075478: Total-Body Irradiation With or Without Fludarabine Phosphate Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer

Completed
3
87
US, Europe
Total-Body Irradiation, TBI, Total Body Irradiation, Whole-Body Irradiation, Fludarabine Phosphate, 2-F-ara-AMP, Beneflur, SH T 586, Mycophenolate Mofetil, Cellcept, MMF, Cyclosporine, 27-400, CsA, Neoral, OL 27-400, Sandimmun, Peripheral Blood Stem Cell Transplantation, PBPC transplantation, Peripheral Blood Progenitor Cell Transplantation, Peripheral Stem Cell Support, Peripheral Stem Cell Transplantation
Fred Hutchinson Cancer Center, National Heart, Lung, and Blood Institute (NHLBI), National Cancer Institute (NCI)
Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, Aggressive Non-Hodgkin Lymphoma, Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Diffuse Large B-Cell Lymphoma, Hematopoietic and Lymphoid Cell Neoplasm, Indolent Non-Hodgkin Lymphoma, Mantle Cell Lymphoma, Myelodysplastic/Myeloproliferative Neoplasm, Plasma Cell Myeloma, Refractory Chronic Lymphocytic Leukemia, Refractory Hodgkin Lymphoma, Waldenstrom Macroglobulinemia
02/14
02/14
NCT00714259: Non-Myeloablative Allogeneic HSCT From HLA Matched Related or Unrelated Donors for the Treatment of Low Grade B Cell Malignancies

Terminated
2/3
5
US
Fludarabine, Total Body Irradiation, Infusion of Stem Cells
University of Alabama at Birmingham
Multiple Myeloma, CLL / SLL, Non Hodgkin's Lymphoma, Waldenstroms, Mantle Cell Lymphoma
02/13
02/13

Download Options